Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Jun 2016 07:00 AM
RNS
Proposed Placing and Amendment to GHIF Bond
07 Jun 2016 07:00 AM
RNS
Business Update
03 May 2016 07:00 AM
RNS
Successful Clinical Trial of Genedrive®
18 Apr 2016 07:00 AM
RNS
Epistem Begins Full Commercial Launch of Genedrive
07 Apr 2016 04:54 PM
RNS
Director/PDMR Shareholding
31 Mar 2016 07:00 AM
RNS
Interim Results
21 Mar 2016 07:42 AM
RNS
Funding award from US Department of Defense
19 Feb 2016 07:00 AM
RNS
Update on CEO Appointment
18 Feb 2016 07:00 AM
RNS
Announces Successful Assessment of Genedrive
13 Jan 2016 07:00 AM
RNS
Epistem Appoints David Budd as CEO
16 Dec 2015 02:18 PM
RNS
Director/PDMR Shareholding
16 Dec 2015 02:11 PM
RNS
Result of AGM
26 Nov 2015 04:41 PM
RNS
Holding(s) in Company
24 Nov 2015 03:28 PM
RNS
Notice of AGM
24 Nov 2015 02:07 PM
RNS
Holding(s) in Company
28 Oct 2015 07:00 AM
RNS
Preliminary Results for year ended 30 June 2015
26 Oct 2015 07:00 AM
RNS
Epistem Holdings Plc - Board Change
20 Oct 2015 07:00 AM
RNS
Notice of Preliminary Results
15 Oct 2015 07:30 AM
RNS
Director/PDMR Shareholding
04 Aug 2015 07:00 AM
RNS
Pre-Close Trading Update and Board Changes
15 Jun 2015 12:17 PM
RNS
Holding(s) in Company
08 Jun 2015 04:49 PM
RNS
Issuance of Shares
18 May 2015 12:45 PM
RNS
NIH Response to UMB proposal
11 May 2015 03:37 PM
RNS
Additional Listing
11 May 2015 11:53 AM
RNS
Directorate Change
23 Apr 2015 07:00 AM
RNS
Regulatory Approval
13 Apr 2015 07:00 AM
RNS
Update re Indian regulatory approval
02 Apr 2015 04:55 PM
RNS
Director/PDMR Shareholding
30 Mar 2015 09:30 AM
RNS
Extension of Director's Options Exercise Period
26 Mar 2015 07:00 AM
RNS
Half Yearly Report
11 Feb 2015 03:21 PM
RNS
Holding(s) in Company
06 Feb 2015 07:48 AM
RNS
Notice of Interim Results
12 Jan 2015 12:19 PM
RNS
Result of AGM
06 Jan 2015 02:50 PM
RNS
Director/PDMR Shareholding
18 Dec 2014 09:08 AM
RNS
Grant of Options
15 Dec 2014 05:26 PM
RNS
Notice of AGM
24 Nov 2014 10:00 AM
RNS
Directorate Change
28 Oct 2014 07:01 AM
RNS
Successful Completion of Genedrive Trials
28 Oct 2014 07:00 AM
RNS
Final Results
07 Oct 2014 07:00 AM
RNS
Notice of Results
28 Jul 2014 09:56 AM
RNS
Additional Listing
22 Jul 2014 07:05 AM
RNS
Pre Close Trading Update
22 Jul 2014 07:00 AM
RNS
Collaborative funding agreement with GHIF
09 May 2014 09:22 AM
RNS
Holding(s) in Company
08 May 2014 05:14 PM
RNS
Holding(s) in Company
01 May 2014 04:37 PM
RNS
Additional Listing
23 Apr 2014 08:45 AM
RNS
Additional Listing
08 Apr 2014 06:21 PM
RNS
Additional Listing
07 Apr 2014 04:44 PM
RNS
Director/PDMR Shareholding
25 Mar 2014 03:00 PM
RNS
Grant of Options

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings